Teva's Generic Evista Approved In The U.S.

Teva announced that its generic equivalent to Evista (raloxifene) 60 mg tablets has been approved in the U.S. The approval makes Teva’s generic version eligible for 180 days of marketing exclusivity.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news